Financial Review: AirSculpt Technologies (AIRS) and The Competition

AirSculpt Technologies (NASDAQ:AIRS) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it contrast to its rivals? We will compare AirSculpt Technologies to related companies based on the strength of its earnings, risk, valuation, institutional ownership, dividends, profitability and analyst recommendations.

Profitability

This table compares AirSculpt Technologies and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AirSculpt Technologies	-6.36%	-9.43%	-4.94%
AirSculpt Technologies Competitors	-7.86%	-135.41%	-1.59%

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for AirSculpt Technologies and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AirSculpt Technologies	1	0	1	0	2.00
AirSculpt Technologies Competitors	1877	7751	13384	833	2.55

AirSculpt Technologies presently has a consensus target price of $2.75, indicating a potential upside of 228.55%. As a group, “Healthcare Providers & Services” companies have a potential upside of 13.45%. Given AirSculpt Technologies’ higher probable upside, equities research analysts clearly believe AirSculpt Technologies is more favorable than its rivals.

Insider & Institutional Ownership

91.5% of AirSculpt Technologies shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares AirSculpt Technologies and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
AirSculpt Technologies	$151.82 million	-$11.67 million	-6.44
AirSculpt Technologies Competitors	$21.44 billion	$301.67 million	-1.73

AirSculpt Technologies’ rivals have higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

AirSculpt Technologies has a beta of 2.29, suggesting that its stock price is 129% more volatile than the S&P 500. Comparatively, AirSculpt Technologies’ rivals have a beta of 0.98, suggesting that their average stock price is 2% less volatile than the S&P 500.

Summary

AirSculpt Technologies rivals beat AirSculpt Technologies on 7 of the 13 factors compared.

About AirSculpt Technologies

AirSculpt Technologies, Inc. provides elective body-contouring and aesthetic procedures through its Elite Body Sculpture centers. Its services include fat removal and fat transfer, using its branded AirSculpt technique, which is designed to remove fat through small entry points without traditional liposuction incisions. The company’s offerings also include procedures that use a patient’s own fat to enhance or reshape areas of the body. AirSculpt Technologies serves patients through centers in the United States and Canada.